Journal
Future Oncology
Publication Date
2020
Volume
16
Issue
12
First Page
749
Last Page
762
Document Type
Open Access Publication
DOI
10.2217/fon-2019-0796
Rights and Permissions
Ponce Aix S, Talbot D, Govindan R, Dols MC, Postmus PE, Lewanski C, Bennouna J, Fischer JR, Juan-Vidal O, Stewart DJ, Ardizzoni A, Bhore R, Wolfsteiner M, Reck M, Ong TJ, Morgensztern D. Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer. Future Oncol. 2020 Apr;16(12):749-762. doi: 10.2217/fon-2019-0796. Epub 2020 Mar 31. This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Recommended Citation
Ponce Aix, Santiago; Govindan, Ramaswamy; Morgensztern, Daniel; and et al, "Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer." Future Oncology. 16, 12. 749 - 762. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9637
